Literature DB >> 11746094

Performance evaluation of QuantiBRITE phycoerythrin beads.

K K Pannu1, E T Joe, S B Iyer.   

Abstract

BACKGROUND: The performance of QuantiBRITE phycoerythrin (PE) beads to standardize quantitation in terms of antibodies bound per cell (ABC) was evaluated by measuring precision, variation across multiple instruments, and variation across time.
METHODS: For CD4 quantitation, whole blood was stained with a two-color CD4 reagent using a no-wash/no-lyse format. For CD69 quantitation, whole blood was activated with either phorbol myristate acetate (PMA) or CD3 beads and then stained with a three-color CD69 reagent using a lyse-no-wash format.
RESULTS: Across 20 normal donors, the mean CD4 ABC was 51,000. Within-assay precision on quantitation of CD4 ABC on T cells had a coefficient of variance (CV) of <1.0%. Across multiple flow cytometers, quantitation of CD4 ABC had a CV of <5.0%. Within-donor CV on CD4 ABC on 20 donors across 2 months ranged from 1.3% to 3.2%. Within-assay precision on quantitation of CD69 on T cells activated with either PMA or CD3 beads had a CV of <3.0%. Within-donor CV of CD69 ABC across 1 month ranged from 2% to 18% on PMA-activated samples and from 7% to 24% on CD3 bead-activated samples.
CONCLUSIONS: Our results indicate that the QuantiBRITE PE beads provide a useful tool for standardized analysis across labs. When used in conjunction with 1:1 conjugates of PE-to-monoclonal antibody, the QuantiBRITE PE beads provide a simple yet robust means of quantitating expression levels in terms of ABC. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746094     DOI: 10.1002/1097-0320(20011201)45:4<250::aid-cyto10021>3.0.co;2-t

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  27 in total

1.  Investigation and development of quantum dot-encoded microsphere bioconjugates for DNA detection by flow cytometry.

Authors:  Sarah Thiollet; Séamus Higson; Nicola White; Sarah L Morgan
Journal:  J Fluoresc       Date:  2011-11-05       Impact factor: 2.217

2.  Quantification and cell-to-cell variation of vascular endothelial growth factor receptors.

Authors:  P I Imoukhuede; Aleksander S Popel
Journal:  Exp Cell Res       Date:  2010-12-23       Impact factor: 3.905

3.  Variables affecting the quantitation of CD22 in neoplastic B cells.

Authors:  Gregory A Jasper; Indu Arun; David Venzon; Robert J Kreitman; Alan S Wayne; Constance M Yuan; Gerald E Marti; Maryalice Stetler-Stevenson
Journal:  Cytometry B Clin Cytom       Date:  2010-09-24       Impact factor: 3.058

4.  Variables in the quantification of CD4 in normals and hairy cell leukemia patients.

Authors:  Lili Wang; Fatima Abbasi; Gregory A Jasper; Robert J Kreitman; David J Liewehr; Gerald E Marti; Maryalice Stetler-Stevenson
Journal:  Cytometry B Clin Cytom       Date:  2011-01       Impact factor: 3.058

5.  Visual inspection versus quantitative flow cytometry to detect aberrant CD2 expression in malignant T cells.

Authors:  Indu Arun; Jacqueline A Wulu; John E Janik; Gregory A Jasper; Constance M Yuan; David Venzon; Maryalice Stetler-Stevenson
Journal:  Cytometry B Clin Cytom       Date:  2010-05       Impact factor: 3.058

6.  Optimized flow cytometry protocol for analysis of surface expression of interleukin-1 receptor types I and II.

Authors:  Filipp Filippovich Vasilyev; Julia Anatolievna Lopatnikova; Sergey Vitalievich Sennikov
Journal:  Cytotechnology       Date:  2013-02-26       Impact factor: 2.058

7.  Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.

Authors:  Saghar Kaabinejadian; Curtis P McMurtrey; Sojung Kim; Rinki Jain; Wilfried Bardet; Fredda B Schafer; Jason L Davenport; Aaron D Martin; Michael S Diamond; Jon A Weidanz; Ted H Hansen; William H Hildebrand
Journal:  J Immunol       Date:  2016-04-20       Impact factor: 5.422

8.  Changes in monocytic expression of aminopeptidase N/CD13 after major trauma.

Authors:  G Huschak; K Zur Nieden; R Stuttmann; D Riemann
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

9.  Neutrophil migration towards C5a and CXCL8 is prevented by non-steroidal anti-inflammatory drugs via inhibition of different pathways.

Authors:  Maria Bertolotto; Paola Contini; Luciano Ottonello; Aldo Pende; Franco Dallegri; Fabrizio Montecucco
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

10.  Cross-arm binding efficiency of an EGFR x c-Met bispecific antibody.

Authors:  Songmao Zheng; Sheri Moores; Stephen Jarantow; Jose Pardinas; Mark Chiu; Honghui Zhou; Weirong Wang
Journal:  MAbs       Date:  2016-01-13       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.